Related Experiment Video
Updated: Nov 24, 2025

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Pregnancy-specific physiologically-based toxicokinetic models for bisphenol A and bisphenol S
Jeremy Gingrich1, David Filipovic2, Rory Conolly3
1Department of Pharmacology and Toxicology, College of Natural Sciences, Michigan State University, East Lansing, MI 48824, USA.
New pregnancy-specific physiologically based toxicokinetic (p-PBTK) models for Bisphenol S (BPS) and Bisphenol A (BPA) show fetal accumulation of these chemicals following maternal exposure. These models aid in assessing risks during pregnancy.
Area of Science:
- Environmental Health
- Toxicology
- Pharmacokinetics
Background:
- Bisphenol S (BPS) is a prevalent environmental chemical detected in humans.
- BPS, like Bisphenol A (BPA), can cross the placenta and affect placental function.
- Existing toxicokinetic models for BPA cannot be directly applied to BPS due to differing properties.
Purpose of the Study:
- To develop pregnancy-specific physiologically based toxicokinetic (p-PBTK) models for both BPA and BPS.
- To utilize a unified model structure for comparing BPA and BPS toxicokinetics during pregnancy.
- To simulate fetal exposure and accumulation of BPA and BPS.
Main Methods:
- Developed nine-compartment p-PBTK models for BPA and BPS.
- Calibrated models using paired maternal and fetal plasma concentration data from pregnant sheep.
- Simulated fetal exposure following daily maternal intake at tolerable daily intake (TDI) levels over two weeks.
Main Results:
- The developed p-PBTK models accurately simulated maternal and fetal BPA and BPS concentrations.
- Simulations demonstrated fetal accumulation of both BPA and BPS with daily maternal exposure.
- Predicted fetal unconjugated BPA levels reached those observed in human cord blood studies.
Conclusions:
- The validated p-PBTK models provide robust predictions of BPA and BPS toxicokinetics during pregnancy.
- These models enhance understanding of fetal exposure to bisphenolic compounds.
- The models serve as a quantitative tool for future risk assessments and related chemical comparisons.
More Related Videos
08:28Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...